BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23324579)

  • 1. ADAM 12: a putative marker of oligodendrogliomas?
    Kanakis D; Lendeckel U; Theodosiou P; Dobrowolny H; Mawrin C; Keilhoff G; Bukowska A; Dietzmann K; Bogerts B; Bernstein HG
    Dis Markers; 2013; 34(2):81-91. PubMed ID: 23324579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
    Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.
    Decaestecker C; Lopes BS; Gordower L; Camby I; Cras P; Martin JJ; Kiss R; VandenBerg SR; Salmon I
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):391-402. PubMed ID: 9100670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
    Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
    J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
    Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
    J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM (a disintegrin and metalloprotease) 12 is expressed in rat and human brain and localized to oligodendrocytes.
    Bernstein HG; Keilhoff G; Bukowska A; Ziegeler A; Funke S; Dobrowolny H; Kanakis D; Bogerts B; Lendeckel U
    J Neurosci Res; 2004 Feb; 75(3):353-60. PubMed ID: 14743448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
    Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.
    Zhuang Z; Qi M; Li J; Okamoto H; Xu DS; Iyer RR; Lu J; Yang C; Weil RJ; Vortmeyer A; Lonser RR
    J Neurosurg; 2011 Oct; 115(4):789-95. PubMed ID: 21682567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
    Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
    Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors.
    Karjalainen SL; Haapasalo HK; Aspatwar A; Barker H; Parkkila S; Haapasalo JA
    BMC Cancer; 2018 May; 18(1):584. PubMed ID: 29792187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas.
    Riemenschneider MJ; Koy TH; Reifenberger G
    Acta Neuropathol; 2004 Mar; 107(3):277-82. PubMed ID: 14730454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
    Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
    J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OLIG2 as a specific marker of oligodendroglial tumour cells.
    Marie Y; Sanson M; Mokhtari K; Leuraud P; Kujas M; Delattre JY; Poirier J; Zalc B; Hoang-Xuan K
    Lancet; 2001 Jul; 358(9278):298-300. PubMed ID: 11498220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
    Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
    Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
    Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
    Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma.
    Wang Y; Hagel C; Hamel W; Müller S; Kluwe L; Westphal M
    Acta Neuropathol; 1998 Oct; 96(4):357-64. PubMed ID: 9797000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.